ArticleDiagnostics (Basel, Switzerland)2021

Validating METCAM/MUC18 as a Novel Biomarker to Predict the Malignant Potential of Prostate Cancer at an Early Stage by Using a Modified Gold Nanoparticles-Based Lateral Flow Immunoassay.

Jui-Chuang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.